Business Description
bioAffinity Technologies is a San Antonio, Texas-based company focused on catching lung cancer early, without the need for invasive procedures. Its main product, CyPath Lung, examines a patient's sputum sample to identify cells that may signal the presence of a lung tumor. Founded in 2014, the company combines advanced cell analysis technology with laboratory services to give doctors a clearer picture of lung health before a disease progresses.
